Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:284293.
doi: 10.1155/2014/284293. Epub 2014 Jan 19.

Values of Alpha 1 Microglobulin Does Not Differ between Individuals with and without Family History of Balkan Endemic Nephropathy

Affiliations

Values of Alpha 1 Microglobulin Does Not Differ between Individuals with and without Family History of Balkan Endemic Nephropathy

Mirna Aleckovic-Halilovic et al. Int J Nephrol. 2014.

Abstract

Aim. The aim of this study was to compare urinary alpha 1 microglobulin (A1MG) in healthy individuals with and without family burden for Balkan endemic nephropathy (BEN) in an endemic village. Methods. Otherwise healthy inhabitants with microalbuminuria or proteinuria were divided into two groups: with (n = 24) and without (n = 32) family BEN burden and screened for urinary A1MG and A1MG/urine creatinine ratio. Results. Average value of urinary A1MG was 10.35 ± 7.01 mg/L in group with and 10.79 ± 8.27 mg/L in group without family history for BEN (NS, P = 0.87). A1MG was higher than 10 mg/L in eight (33.33%) inhabitants with family history and in 12 (37.5%) without (NS, P = 0.187). Average values of urinary A1MG/creatinine ratio were 1.30 ± 1.59 and 0.94 ± 0.78 in group with and group without family BEN history (NS, P = 0.39, resp.). Elevated values of this ratio were found in 13 (54.17%) inhabitants with and 14 (43.75%) without family history for BEN (NS, P = 0.415). Conclusion. We did not find statistically significant difference in the examined markers between healthy individuals with and without family burden for BEN. We concluded that these markers are not predictive of risk for BEN.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Batuman V. Fifty years of Balkan endemic nephropathy: daunting questions, elusive answers. Kidney International. 2006;69(4):644–646. - PubMed
    1. Bamias G, Boletis J. Balkan nephropathy: evolution of our knowledge. American Journal of Kidney Diseases. 2008;52(3):606–616. - PMC - PubMed
    1. De Broe ME. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy. Kidney International. 2012;81(6):513–515. - PubMed
    1. Raicevic S, Trnacevic S, Hranisavljevic J, Vucelic D. Renal function, protein excretion, and pathology of Balkan endemic nephropathy. II. Protein excretion. Kidney International. 1991;40(supplement 34):S-52–S-56. - PubMed
    1. Ikeda M, Ezaki T, Tsukahara T, et al. Reproducibility of urinary cadmium, alpha1-microglobulin, and beta2-microglobulin levels in health screening of the general population. Archives of Environmental Contamination and Toxicology. 2005;48(1):135–140. - PubMed

LinkOut - more resources